Therapy
Pharmaceutical
Health

Albireo Pharma

$33.75
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.00 (-2.88%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell Albireo Pharma and other stocks, options, ETFs, and crypto commission-free!

About

Albireo Pharma, Inc. Common Stock, also called Albireo Pharma, is a pharmaceutical company, which engages in the development and commercialization of bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Read More Its product pipeline includes A4250, Elobixibat, and A3384. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA.

Employees
39
Headquarters
Boston, Massachusetts
Founded
2003
Market Cap
418.35M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
54.07K
High Today
$34.45
Low Today
$33.44
Open Price
$34.45
Volume
23.29K
52 Week High
$38.69
52 Week Low
$19.10

Collections

Therapy
Pharmaceutical
Health

News

Yahoo FinanceMay 2

Albireo to Report First Quarter 2019 Financial Results and Host Conference Call and Webcast

BOSTON, May 02, 2019 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced that management will host a conference call and live audio webcast at 10 a.m. EDT on May 9, 2019, to review the first quarter ended March 31, 2019, financial results and provide a business update. To access the live conference call by phone, dial 877-407-0792 (domestic) or 201-689-8263 (international), and provide the access c...

27

Earnings

-$1.39
-$0.34
$0.72
$1.77
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
-$1.32 per share
Actual
-$1.39 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.